» Articles » PMID: 39544874

Association of Single Nucleotide Polymorphisms (SNPs) with Obesity Risk in Different Populations: A Systematic Review and Analysis

Overview
Date 2024 Nov 15
PMID 39544874
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Thirty-two single nucleotide polymorphisms (SNPs) are commonly found in . APN levels are decreased in obesity, and SNPs of the gene affecting APN have varying associations with the development of obesity in different populations. This systematic review and meta-analysis aimed to investigate the association of SNPs in with the risk of obesity development in various populations.

Methods: A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist date up to Feb 2023. We used the Newcastle-Ottawa scale to find out if a study fit the main criteria for submission and to assess the data quality of the articles included in the systematic review and meta-analysis. Odds ratios (OR) and 95% confidence intervals (CI) were calculated via Review Manager (RM) V.5.4 to estimate the connection between polymorphic qualities of a gene and the risk of developing obesity.

Results: The present study analysed the association between polymorphisms (rs1501299, rs2241766, rs266729, rs822393, and rs822396) and obesity risk and suggested that APN is partially responsible for the emergence of obesity and increases its risk.

Conclusion: It is important to take into account several limitations of this meta-analysis when evaluating the findings. First off, even though we looked through numerous databases for all relevant papers, there is a chance we overlooked some. Our capacity to arrive at more firm conclusions was further hampered by the small number of papers that made up our meta-analysis. The most current data, however, are presented in this study since it used newly published data to perform a meta-analysis and evaluate the relationship between ADIPOQ polymorphisms and obesity.

References
1.
Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Ben Rejeb N, Nabli N . Association between eight adiponectin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers. Metab Syndr Relat Disord. 2011; 9(6):419-26. DOI: 10.1089/met.2011.0035. View

2.
Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

3.
Ergoren M, Soyler G, Sah H, Becer E . Investigation of potential genomic biomarkers for obesity and personalized medicine. Int J Biol Macromol. 2018; 122:493-498. DOI: 10.1016/j.ijbiomac.2018.10.059. View

4.
Selvakumaran S, Lin C, Hadgraft N, Chandrabose M, Owen N, Sugiyama T . Area-level socioeconomic inequalities in overweight and obesity: Systematic review on moderation by built-environment attributes. Health Place. 2023; 83:103101. DOI: 10.1016/j.healthplace.2023.103101. View

5.
Beebe-Dimmer J, Zuhlke K, Ray A, Lange E, Cooney K . Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis. 2010; 13(4):362-8. PMC: 2978765. DOI: 10.1038/pcan.2010.27. View